Globally, the cell lysis market is witnessing high growth due to factors such as increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on personalized medicine. On the other hand, high cost of cell-based research is expected to restrain the growth of this market during the forecast period. Key players are focusing on enhancing their products to increase their shares in the market. Companies are focusing on the strategies of new product launches, partnerships, agreements, & collaborations, acquisitions, and expansions to strengthen their foothold in the market.
Based on product, the cell lysis market is segmented into consumables and instruments. Consumables include reagents and kits, beads, and disposables. Reagents and kits are further classified into enzymes, detergent solutions, and other reagents and kits. Consumables is expected to account for largest share of the market. The large share of this market is attributed to the increasing use of reagents and kits for cell disruption and rising company initiatives to develop and launch new cell lysis products. The instruments segment comprises sonicators, homogenizers, and other instruments. Sonicators account for the largest share in the instruments market.
Based on type of cell, the cell lysis market is segmented into mammalian cells, microbial cells, and other cells. The mammalian cell segment is poised to witness the highest growth rate in this market due to their increasing use for development of new cell therapies. Also, rising prevalence of infectious diseases urge a need for advanced treatment options that will help to increase the market growth of microbial cells.
Based on end-user, the cell lysis market is segmented into research laboratories and institutes, biopharmaceutical and biotechnology companies, and others. The research laboratories and institutes segment is poised to witness the highest growth rate in this market due to increasing prevalence of diseases and rising government investments. Increasing number of biotechnology firms across the globe and rising investments by companies in cell-based research provide a major impetus to the growth of biopharmaceutical and biotechnology companies market.
In the coming five years, growth in the cell lysis market is likely to be centered in Asia. Growth in this region can be attributed to the high prevalence diseases. Furthermore, increasing initiatives by companies to expand their distribution network and large customer base in the Asia region is further driving the growth of this market.